A Stanford Medicine study of 22,281 UK Biobank cancer patients found mental health disorders identified two to five years after diagnosis were associated with a 119 percent higher rate of death from cancer.
Mental health disorders identified two to five years after a cancer diagnosis were associated with a 119 percent higher rate of death from cancer, a Stanford Medicine study has found, pointing to an often-overlooked period of vulnerability in survivorship.
Published in the Journal of the National Cancer Institute, the study analyzed data from 22,281 UK Biobank participants diagnosed with cancer over a median follow-up of more than five years. Researchers examined how the timing of mental health diagnoses related to cancer-specific survival, and the strongest association appeared two to five years after diagnosis, a pattern seen across major cancer types including breast, prostate, lung and lymphoma, with colorectal cancer showing a similar rate in the first year.
The findings do not establish that mental illness causes cancer progression, Stanford Medicine stresses, nor do they explain how cancer may contribute to mental disorders. Instead, mental health diagnoses may help identify patients experiencing psychological distress, treatment complications, barriers to care or other challenges associated with poorer survival, and gaps in ongoing support could be one contributor, the researchers say.
The study's numbers come from Stanford Medicine's own account of the peer-reviewed paper, and the association it reports is a statistical link rather than proof of cause: patients with documented mental disorders in that two-to-five-year window died from cancer at a higher rate than patients without such diagnoses in the same period, but the study does not show that treating the mental disorder would by itself change the cancer outcome.
The authors argue that routine mental health screening and comprehensive support should be part of cancer care well into survivorship, not only during initial treatment. Lead author Mingyi Li and senior author Melissa Bondy, of the Stanford Cancer Institute, frame the implication as practical: follow-up care that stops watching for distress after the first year may miss the window when patients are most at risk.